Weilai Li Bin: Fang Hongbo, chairman of Midea, became the chief experience officer of Weilai ET9, and will test drive together. Li Bin, founder, chairman and CEO of Weilai, released Weibo on December 12th, saying that Fang Hongbo, chairman of Midea, became the chief experience officer of Weilai ET9, and will test drive this upcoming administrative flagship together. Li Bin said that he asked Fang Hongbo three questions, and Fang Hongbo's answer about market competition was very good: "Actively participate in involution, compare cost and efficiency, and at the same time bravely jump out of involution, don't roll on the floor, and pierce the ceiling."Zhongjing Technology: Changzhou Jinhong, a shareholder, intends to reduce its shareholding by no more than 3%. Zhongjing Technology announced that Changzhou Jinhong Enterprise Management Partnership (Limited Partnership), a shareholder holding more than 5%, intends to reduce its shareholding in the company by means of centralized bidding and block trading, with the reduction amount not exceeding 18,886,100 shares, that is, not exceeding 3% of the company's total share capital. The reduction price will be determined according to the market price when the reduction is implemented. This reduction will be carried out within three months after 15 trading days from the date of disclosure of this announcement."39 people were pardoned and nearly 1,500 people were commuted", White House: Biden announced "the largest single-day commutation action in modern history", CBS, NBC and other media reported that the White House issued a statement on the 12th local time, saying that US President Biden announced that he would pardon 39 Americans convicted of non-violent crimes and commute the sentences of nearly 1,500 people who were released at home during the COVID-19 epidemic. According to the White House statement, this move represents "the largest single-day commutation action in modern history" in the United States. According to the statement, Biden said that he will take more relevant measures in the next few weeks and will continue to review petitions for pardon and commutation. (World Wide Web)
Xinxuan Group: The sales volume of the "Xin Huo Plan" is nearly 2 billion yuan, and Xinxuan Group disclosed the sales data of the live broadcast of the "Xin Huo Plan" in Shanxi Station. Statistics show that the two live broadcasts brought a total of 3.67 million orders, helping Shanxi specialty products with sales exceeding 180 million yuan to go nationwide. It is understood that this activity is guided by the Shanxi Provincial Department of Commerce. According to the disclosure, Xinxuan Group's "Xin Huo Plan" went to the whole country to carry out a number of live broadcast activities to help farmers, with sales of nearly 2 billion yuan. In addition, Xinxuan Group has donated a total of nearly 400 million yuan to the society. (Sina Technology)Market news: Brazilian President Lula should be able to leave the hospital early next week.Market News: The Slovak Prime Minister said that Slovakia supports the normalization of relations between Russia and western countries and opposes the emergence of a new iron curtain in Europe. The Slovak Prime Minister emphasized that all conflicts will be finally resolved through negotiations.
Japanese government bond futures rose, recovering some of the earlier declines.South Korea's National Election Commission: South Korean President Yin Xiyue's remarks undermined South Korea's electoral system.Huadong Pharmaceutical has established a new company in Jiaxing with a registered capital of 60 million yuan. According to Tianyancha App, Huadong Pharmaceutical (Jiaxing) Co., Ltd. was recently established with Zhu Li as its legal representative and a registered capital of 60 million yuan. Its business scope includes drug wholesale, drug retail, decoction service for Chinese herbal pieces, third-class medical device operation, drug Internet information service, drug import and export, third-class medical device rental and medical device Internet information service. According to shareholder information, the company is wholly owned by Huadong Pharmaceutical (000963).
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14